We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-4.59%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17B
AUM Growth
-$724M
(-4.1%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
1,117
New
28
Increased
595
Reduced
447
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$226M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$86.1M |
| 3 |
Tesla
TSLA
|
+$57.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.5M |
| 5 |
Rambus
RMBS
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$109M |
| 2 |
Broadcom
AVGO
|
+$52.1M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$44.7M |
| 4 |
Intel
INTC
|
+$34.2M |
| 5 |
ON Semiconductor
ON
|
+$29.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.96% |
| 2 | Financials | 10.65% |
| 3 | Healthcare | 7.83% |
| 4 | Consumer Discretionary | 4.77% |
| 5 | Energy | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Cogent Biosciences
COGT
$6.65B
| $1.87M | 0.01% |
191,777
-14,366
| -7% | -$170K |
|
627
Vera Therapeutics
VERA
$2.3B
| $1.87M | 0.01% |
+136,377
| New | +$2.34M |
|
628
Expedia Group
EXPE
$35.4B
| $1.87M | 0.01% |
18,104
-14,154
| -44% | -$1.56M |
|
629
Labcorp
LH
$25B
| $1.86M | 0.01% |
9,241
-809
| -8% | -$171K |
|
630
World Kinect Corp
WKC
$2.04B
| $1.86M | 0.01% |
82,750
+24,982
| +43% | +$557K |
|
631
Keros Therapeutics
KROS
$199M
| $1.86M | 0.01% |
58,189
-12,067
| -17% | -$450K |
|
632
Expeditors International
EXPD
$22B
| $1.85M | 0.01% |
16,127
-1,017
| -6% | -$121K |
|
633
Pinterest
PINS
$13.4B
| $1.83M | 0.01% |
67,852
+6,525
| +11% | +$178K |
|
|
CDMO
634
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.83M | 0.01% |
193,879
-10,544
| -5% | -$127K |
|
635
Albemarle
ALB
$13.9B
| $1.83M | 0.01% |
10,742
+1,213
| +13% | +$242K |
|
636
Mohawk Industries
MHK
$7.5B
| $1.82M | 0.01% |
21,209
+5,547
| +35% | +$559K |
|
637
LyondellBasell Industries
LYB
$20B
| $1.81M | 0.01% |
19,081
+2,151
| +13% | +$207K |
|
638
Cabaletta Bio
CABA
$437M
| $1.8M | 0.01% |
+118,150
| New | +$1.61M |
|
639
FirstEnergy
FE
$28B
| $1.8M | 0.01% |
52,606
+2,907
| +6% | +$108K |
|
640
Aldeyra Therapeutics
ALDX
$92.9M
| $1.79M | 0.01% |
268,690
+15,469
| +6% | +$115K |
|
641
WaFd
WAFD
$2.72B
| $1.79M | 0.01% |
69,876
-64,059
| -48% | -$1.79M |
|
642
First Financial Bankshares
FFIN
$5.04B
| $1.79M | 0.01% |
71,239
-55,654
| -44% | -$1.61M |
|
|
STR
643
DELISTED
Sitio Royalties
STR
| $1.79M | 0.01% |
73,910
-15,506
| -17% | -$399K |
|
644
United Airlines
UAL
$39.4B
| $1.78M | 0.01% |
42,110
-9,087
| -18% | -$459K |
|
|
DCPH
645
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.78M | 0.01% |
139,740
-91,351
| -40% | -$1.26M |
|
|
HOLX
646
DELISTED
Hologic
HOLX
| $1.77M | 0.01% |
25,564
+1,787
| +8% | +$135K |
|
647
Anavex Life Sciences
AVXL
$255M
| $1.77M | 0.01% |
270,788
-79,874
| -23% | -$636K |
|
|
PPL
648
PPL Corp
PPL
$26.5B
| $1.77M | 0.01% |
75,116
+7,731
| +11% | +$200K |
|
|
SLRN
649
DELISTED
ACELYRIN
SLRN
| $1.77M | 0.01% |
+173,696
| New | +$3.69M |
|
650
Hexcel
HXL
$7.79B
| $1.76M | 0.01% |
27,069
+1,651
| +6% | +$117K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Rafferty Asset Management held 1,117 positions worth $17B, down 4.1% from $17.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management's Q3 2023 filing shows 28 new, 595 increased, 447 reduced and 45 closed positions. Its largest new stake was Rambus: 596,990 shares worth $33.3M. The largest sale was NVIDIA, an estimated $109M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 46% a quarter earlier, followed by Financials and Healthcare.
- Rafferty Asset Management's largest Q3 2023 buy was Rambus: 596,990 shares worth $33.3M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2023, an estimated $226M increase.
- Rafferty Asset Management's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $109M.
- Rafferty Asset Management fully exited Silicon Laboratories in Q3 2023, selling an estimated $28.9M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17B portfolio in Q3 2023.
- Rafferty Asset Management opened 28 new positions and closed 45 in Q3 2023.
- Rafferty Asset Management's portfolio value fell 4.1% quarter-over-quarter to $17B.
Based on Rafferty Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.